CDH2 and urinary bladder cancer: In large multi-institution retrospective studies, Ki-67, HER-2, EGFR, and N-cadherin were independent prognostic factors for bladder cancer recurrence after RNU and could be used as markers for intravesical therapies and bladder surveillance.